Apolipoprotein B (apoB) is the major protein of plasma very low density lipoprotein (VLDL) and low density lipoprotein (LDL). Here we report the molecular cloning of cDNAs for rabbit liver apoB, by use of the expression vector Xgtll, and the use of these cDNAs to study the regulation of apoB mRNA levels by dietary cholesterol. The j-galactosidaseapoB fusion proteins expressed by recombinant clones were identified with guinea pig anti-rabbit LDL antibodies. The cloned cDNAs hybridized to an 18-kilobase mRNA that was present in liver and intestine. Slot blot analysis showed that this mRNA was not present in other tissues studied, with the possible exception of kidney. When rabbits are fed a highcholesterol diet, they develop severe hypercholesterolemia.Most of the excess cholesterol is contained in .3-VLDL, a cholesteryl ester-rich lipoprotein that contains apoB and apoE. We addressed the question of whether increased apoB mRNA levels, and by inference increased apoB synthetic rates, are responsible for the accumulation of ,l-VLDL. A comparison of apoB mRNA levels showed that cholesterol-fed rabbits had lower liver apoB mRNA levels than control rabbits. We suggest that the accumulation of plasma 83-VLDL in cholesterol-fed rabbits is not due to an increased production of fi-VLDL but solely due to a suppression of hepatic LDL receptors.Apolipoprotein B (apoB) plays a central role in cholesterol metabolism. It is an obligatory constituent of chylomicrons, very low density lipoproteins (VLDL), and low density lipoproteins (LDL) (1). Circulating apoB exists in two forms which are immunologically related. ApoB-100 has a molecular weight of about 400,000 and is made in the liver, whereas apoB-48 has a molecular weight of about 200,000 and is made in the intestine (2, 3). The liver secretes apoB-100 into circulation as a structural protein of triacylglycerol-rich VLDL, which is converted to cholesterol-rich LDL by the action of lipoprotein lipase (4). Despite the abundance of apoB in plasma, its structure and biosynthesis have not been well-characterized. This in large part is due to its size, its insolubility when delipidated, its tendency to aggregate, and its susceptibility to oxidation. Some progress has recently been made, however, with the identification and sequencing of partial cDNA clones for human and rat apoB (5-10). The concentration of plasma LDL is strongly correlated with the risk of coronary heart disease. Two factors regulate the plasma concentration of LDL: (i) the rate of VLDL synthesis and (ii) the receptor-dependent removal of LDL from circulation. The importance of the LDL receptor in the regulation of plasma cholesterol levels has been demonstrated (11). However, the question of whether the production rate of apoB contributes to elevated LDL cholesterol levels remains unclear, although evidence from a number of studies suggests that alterations in the regulation of apoB synthesis may contribute to hypercholesterolemia and atherosclerosis (12)(13)(14).To address the question of the regulation...